Temporal immunological marker risk model for predicting severity of COVID-19 outcomes: early risers, late bloomers and general giants

Abstract

Treatment strategies for severe COVID-19 presentations have improved. However, predicting severity early remains a challenge, as the onset of deterioration is highly variable and difficult to recognise. Patients showing late deterioration are particularly affected by limited treatment options. A